MAX Tussin Mucus and Chest Congestion Sugar Free
NDC 71399-0024, Guaifenesin, liquid, from Akron Pharma Inc..
- Product NDC
- 71399-0024
- Status
- Listed
- Labeler
- Akron Pharma Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71399-0024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN200 mg/10mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71399-0024-4 | 71399002404 | 1 BOTTLE, PLASTIC in 1 PACKAGE (71399-0024-4) / 118 mL in 1 BOTTLE, PLASTIC |
| 71399-0024-6 | 71399002406 | 473 mL in 1 BOTTLE, PLASTIC (71399-0024-6) |
| 71399-0024-8 | 71399002408 | 1 BOTTLE, PLASTIC in 1 PACKAGE (71399-0024-8) / 236 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71399-0024 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71399-0024 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71399-0024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.